Shandong Sinobioway Biomedicine News

Unnamed Pharmaceuticals: Explanation and Verification Opinions of the Supervisory Board on the Publication of the Company\'s 2024 Stock Option Incentive Plan Incentive List

Dec 12 11:00 ET

Unnamed Pharmaceuticals: Announcement on the progress of the transfer of shares in participating companies through public listing

Dec 6 11:00 ET

Unnamed Pharmaceuticals: Announcement on the Change of Chief Financial Officer

Dec 5 11:00 ET

Unnamed Medicine: Announcement of Resolutions of the 30th Meeting of the Fifth Board of Directors

Dec 5 11:00 ET

Unnamed Pharmaceuticals: An indicative announcement on the adoption of an autonomous exercise model during the first exercise period of the 2023 Stock Options Incentive Plan

Dec 5 11:00 ET

Unnamed Pharmaceuticals: Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan Implementation Assessment Measures

Dec 2 11:00 ET

Unnamed Pharmaceutical: Notice on requesting the shareholders\' meeting to authorize the board of directors to handle matters relating to the company\'s 2024 stock option incentive plan

Dec 2 11:00 ET

Unnamed Medicine: Announcement on the By-election of Independent Directors of the 5th Board of Directors and the Adjustment of Members of the Special Committee of the Board

Dec 2 11:00 ET

Unnamed Medicine: Announcement of Resolutions of the 20th Meeting of the Fifth Board of Supervisors

Dec 2 11:00 ET

Unnamed Medicine: 2024-069 Announcement of Resolutions of the 29th Meeting of the Fifth Board of Directors

Dec 2 11:00 ET

Unnamed Medicine: Legal Opinion of Zhejiang Tianzu (Shenzhen) Law Firm on Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan (Draft)

Dec 2 11:00 ET

Unnamed Pharmaceuticals: Supervisory Board\'s Review Opinions on Matters Related to the 2024 Stock Options Incentive Plan

Dec 2 11:00 ET

Unnamed Pharmaceuticals: Independent Director Candidate Statements and Commitments - Cai Yanhong

Dec 2 11:00 ET

Unnamed Pharmaceuticals: Draft Equity Incentive Plan Self-Inspection Form

Dec 2 11:00 ET

Unnamed Pharmaceuticals: Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan Draft (Summary)

Dec 2 11:00 ET

Unnamed Pharmaceuticals: Independent Director Nominee\'s Statement and Commitment - Cai Yanhong

Dec 2 11:00 ET

Unnamed Pharmaceuticals: Notice on Convening the Fourth Extraordinary General Meeting of Shareholders in 2024

Dec 2 11:00 ET

Unnamed Medicine: Independent Directors\' Open Call for Delegated Voting Rights Report

Dec 2 11:00 ET

Weiming Pharmaceutical: Shandong Weiming Biomedical Co., Ltd. 2024 Stock Option Incentive Plan (Draft)

Dec 2 11:00 ET

Unnamed Pharmaceuticals: 2024 Stock Option Incentive Plan Incentive List

Dec 2 11:00 ET